纳斯达克生物科技指数跌幅扩大至5.38%。成分股Syndax Pharmaceuticals跌21.37%,Taysha Gene跌18.25%,uniQure NV跌17.94%表现目前倒数第三。
快讯·2025-05-07 01:14
生物制药行业股价表现 - Syndax Pharmaceuticals股价下跌21.67%至10.63美元,交易量达3.85M [1][2] - Taysha Gene Therapies股价下跌18.07%至2.015美元,交易量为3.54M [1][2] - uniQure NV股价下跌17.68%至13.08美元,交易量1.73M [1][2] 其他显著下跌个股 - Inozyme Pharma股价下跌16.13%至1.25美元,交易量831.95K [2] - Replimune Group股价下跌15.90%至8.42美元,交易量540.76K [2] - Lexeo Therapeutics股价下跌15.73%至3.75美元,交易量487.1K [2] 中跌幅个股集群 - Olema Pharmaceuticals下跌15.56%至4.70美元,交易量577.19K [2] - Neurogene下跌15.02%至12.84美元,交易量114.89K [2] - ORIC Pharmaceuticals下跌14.47%至4.87美元,交易量399.74K [2] 大型药企表现 - Vertex Pharmaceuticals下跌13.17%至434.34美元,交易量达4.7M [2] - Krystal Biotech下跌13.28%至140.75美元,交易量748.86K [2] - Rocket Pharmaceuticals下跌12.99%至6.83美元,交易量1.59M [2]